Your browser doesn't support javascript.
loading
Low-level overexpression of wild type TDP-43 causes late-onset, progressive neurodegeneration and paralysis in mice.
Yang, Chunxing; Qiao, Tao; Yu, Jia; Wang, Hongyan; Guo, Yansu; Salameh, Johnny; Metterville, Jake; Parsi, Sepideh; Yusuf, Issa; Brown, Robert H; Cai, Huaibin; Xu, Zuoshang.
Afiliación
  • Yang C; Department of Biochemistry and Molecular Biotechnology, University of Massachusetts Medical School, Worcester, Massachusetts, United States of America.
  • Qiao T; Department of Biochemistry and Molecular Biotechnology, University of Massachusetts Medical School, Worcester, Massachusetts, United States of America.
  • Yu J; Transgenics Section, Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, United States of America.
  • Wang H; Department of Biochemistry and Molecular Biotechnology, University of Massachusetts Medical School, Worcester, Massachusetts, United States of America.
  • Guo Y; Department of Biochemistry and Molecular Biotechnology, University of Massachusetts Medical School, Worcester, Massachusetts, United States of America.
  • Salameh J; Department of Neurology, University of Massachusetts Medical School, Worcester, Massachusetts, United States of America.
  • Metterville J; Department of Neurology, University of Massachusetts Medical School, Worcester, Massachusetts, United States of America.
  • Parsi S; Department of Biochemistry and Molecular Biotechnology, University of Massachusetts Medical School, Worcester, Massachusetts, United States of America.
  • Yusuf I; Department of Biochemistry and Molecular Biotechnology, University of Massachusetts Medical School, Worcester, Massachusetts, United States of America.
  • Brown RH; Department of Neurology, University of Massachusetts Medical School, Worcester, Massachusetts, United States of America.
  • Cai H; RNA Therapeutic Institute, University of Massachusetts Medical School, Worcester, Massachusetts, United States of America.
  • Xu Z; Neuroscience Program, University of Massachusetts Medical School, Worcester, Massachusetts, United States of America.
PLoS One ; 17(2): e0255710, 2022.
Article en En | MEDLINE | ID: mdl-35113871

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Esclerosis Amiotrófica Lateral Tipo de estudio: Etiology_studies / Prognostic_studies Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Esclerosis Amiotrófica Lateral Tipo de estudio: Etiology_studies / Prognostic_studies Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos